Rare mutations in RINT1 predispose carriers to breast and lynch syndrome-Spectrum cancers

Cancer Discovery

Volumn 4, Issue 7, 2014, Pages 804-815

  Park, Daniel J ^a   Tao, Kayoko ^f   Le Calvez Kelm, Florence ^o   Nguyen Dumont, Tu ^a   Robinot, Nivonirina ^o   Hammet, Fleur ^a   Odefrey, Fabrice ^a   Tsimiklis, Helen ^a   Teo, Zhi L ^a   Thingholm, Louise B ^a   Young, Erin L ^f   Voegele, Catherine ^o   Lonie, Andrew ^c   Pope, Bernard J ^a,c   Roane, Terrell C ^h   Bell, Russell ^f   Hu, Hao ⁱ   Shankaracharya, ⁱ   Huff, Chad D ⁱ   Ellis, Jonathan ^e   Li, Jun ^e   Makunin, Igor V ^e   John, Esther M ^j,k   Andrulis, Irene L ^q   Terry, Mary B ^l   Daly, Mary ^m   Buys, Saundra S ^g   Snyder, Carrie ⁿ   Lynch, Henry T ⁿ   Devilee, Peter ^r   Giles, Graham G ^b,d   Hopper, John L ^b,s   Feng, Bing Jian ^g   Lesueur, Fabienne ^o,p   Tavtigian, Sean V ^f   Southey, Melissa C ^a   Goldgar, David E ^g   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Victorian Life Sciences Computation Initiative   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF UTAH   (United States)

^h UNIVERSITY OF TEXAS AT AUSTIN   (United States)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^k STANFORD CANCER INSTITUTE   (United States)

^l Cancer Prevention Institute of California ^*  (United States)

^m FOX CHASE CANCER CENTER   (United States)

ⁿ CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^p INSERM   (France)

^q MOUNT SINAI HOSPITAL   (Canada)

^r LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^s Seoul National University   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RINT1 GENE; RNA SPLICING; SCREENING; SEQUENCE ALIGNMENT; BREAST TUMOR; DNA SEQUENCE; EXOME; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; MUTATION; PEDIGREE;

CELL CYCLE PROTEIN; RINT1 PROTEIN, HUMAN;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MUTATION; PEDIGREE; SEQUENCE ANALYSIS, DNA;

EID: 84904049854     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-14-0212     Document Type: Article

References (49)

1. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77: 2318-24.
2. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-8.
3. Hemminki K, Granstrom C, Czene K. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden. Int J Cancer 2002; 100: 214-9.
4. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013; 45: 353-61, 361e1.
5. Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet 2012; 8: e1002894.
6. Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, et al. Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet 2012; 90: 734-9.
7. Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 2013; 493: 406-10.
8. Snape K, Ruark E, Tarpey P, Renwick A, Turnbull C, Seal S, et al. Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer. Breast Cancer Res Treat 2012; 134: 429-33.
9. Feng BJ, Tavtigian SV, Southey MC, Goldgar DE. Design considerations for massively parallel sequencing studies of complex human disease. PLoS ONE 2011; 6: e23221.
10. Park DJ, Odefrey FA, Hammet F, Giles GG, Baglietto L, ABCFS, et al. FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer. Breast Cancer Res Treat 2011; 130: 1043-9.
11. Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, et al. Rare variants in XRCC2 as breast cancer susceptibility alleles. J Med Genet 2012; 49: 618-20.
12. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005; 42: 711-9.
13. Mocci E, Milne RL, Mendez-Villamil EY, Hopper JL, John EM, Andrulis IL, et al. Risk of pancreatic cancer in breast cancer families from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 2013: 22: 803-11.
14. Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, et al. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 2013; 105: 274-9.
15. Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013; 34: 490-7.
16. Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst 2012; 104: 1363-72.
17. Bellizzi AM, Frankel WL. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 2009; 16: 405-17.
18. Hu H, Roach JC, Coon H, Guthery SL, Voelkerding KV, Margraf RL, et al. A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data. Nature Biotechnol. 2014 May 18. [Epub ahead of print].
19. Yandell M, Huff C, Hu H, Singleton M, Moore B, Xing J, et al. A probabilistic disease-gene finder for personal genomes. Genome Res 2011; 21: 1529-42.
20. Hu H, Huff CD, Moore B, Flygare S, Reese MG, Yandell M. VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix. Genet Epidemiol 2013; 37: 622-34.
21. Xiao J, Liu CC, Chen PL, Lee WH. RINT-1, a novel Rad50-interacting protein, participates in radiation-induced G(2)/M checkpoint control. J Biol Chem 2001; 276: 6105-11.
22. Lin X, Liu CC, Gao Q, Zhang X, Wu G, Lee WH. RINT-1 serves as a tumor suppressor and maintains Golgi dynamics and centrosome integrity for cell survival. Mol Cell Biol 2007; 27: 4905-16.
23. Sun Y, Shestakova A, Hunt L, Sehgal S, Lupashin V, Storrie B. Rab6 regulates both ZW10/RINT-1 and conserved oligomeric Golgi complex-dependent Golgi trafficking and homeostasis. Mol Biol Cell 2007; 18: 4129-42.
24. Wainman A, Giansanti MG, Goldberg ML, Gatti M. The Drosophila RZZ complex-roles in membrane trafficking and cytokinesis. J Cell Sci 2012; 125: 4014-25.
25. Schmitt HD. Dsl1p/Zw10: common mechanisms behind tethering vesicles and microtubules. Trends Cell Biol 2010; 20: 257-68.
26. Civril F, Wehenkel A, Giorgi FM, Santaguida S, Di Fonzo A, Grigorean G, et al. Structural analysis of the RZZ complex reveals common ancestry with multisubunit vesicle tethering machinery. Structure 2010; 18: 616-26.
27. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res es 2004; 6: R375-89.
28. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 2006; 8: R12.
29. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 2006; 45: 646-55.
30. Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet 2009; 85: 427-46.
31. Le Calvez-Kelm F, Lesueur F, Damiola F, Vallee M, Voegele C, Babikyan D, et al. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Res 2011; 13: R6.
32. Le Calvez-Kelm F, Oliver J, Damiola F, Forey N, Robinot N, Durand G, et al. RAD51 and breast cancer susceptibility: no evidence for rare variant association in the breast cancer family registry study. PLoS ONE 2012; 7: e52374.
33. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-60.
34. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010; 26: 841-2.
35. Pope BJ, Nguyen-Dumont T, Odefrey F, Hammet F, Bell R, Tao K, et al. FAVR (Filtering and Annotation of Variants that are Rare): methods to facilitate the analysis of rare germline genetic variants from massively parallel sequencing datasets. BMC Bioinformatics 2013; 14: 65.
36. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010: 38: e164.
37. Voegele C, Tavtigian SV, de Silva D, Cuber S, Thomas A, Le Calvez-Kelm F. A Laboratory Information Management System (LIMS) for a high throughput genetic platform aimed at candidate gene mutation screening. Bioinformatics 2007; 23: 2504-6.
38. Nguyen-Dumont T, Calvez-Kelm FL, Forey N, McKay-Chopin S, Garritano S, Gioia-Patricola L, et al. Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis. Hum Mutat 2009; 30: 884-90.
39. Garritano S, Gemignani F, Voegele C, Nguyen-Dumont T, Le Calvez-Kelm F, De Silva D, et al. Determining the effectiveness of high resolution melting analysis for SNP genotyping and mutation scanning at the TP53 locus. BMC Genet 2009; 10: 5.
40. Felsenstein J. PHYLIP-Phylogeny Inference Package (version 3.2). Cladistics 1989; 5: 164-6.
41. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11: 377-94.
42. Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A. Classification of rare missense substitutions, using risk surfaces, with genetic-and molecular-epidemiology applications. Hum Mutat 2008; 29: 1342-54.
43. Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 2007; 81: 873-83.
44. Southey MC, Tesoriero A, Young MA, Holloway AJ, Jenkins MA, Whitty J, et al. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. Hum Mutat 2003; 22: 86-91.
45. Teo ZL, Park DJ, Provenzano E, Chatfield CA, Odefrey FA, Nguyen-Dumont T, et al. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res 2013; 15: R17.
46. Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, et al. Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 2011; 13: R73.
47. Southey MC, Teo ZL, Dowty JG, Odefrey FA, Park DJ, Tischkowitz M, et al. A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res 2010; 12: R109.
48. Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 1988; 5: 471-2.
49. Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator (NIH Publication 79-1649). Washington, DC: US Government Printing Office; 1979.